1. Field of the Invention
The invention generally relates to ophthalmic lenses and, more particularly, the invention relates to ophthalmic lenses for increasing the depth of focus of the human eye.
2. Description of the Related Art
It is well-known that the depth of focus of the human eye can be increased with the use of ophthalmic lenses with pinhole-like apertures substantially near the optical center of the lens. For example, U.S. Pat. No. 4,976,732 (“the '732 patent”) discloses an ophthalmic lens with a pinhole-like aperture. In the '732 patent, a mask forms the pinhole-like aperture. In one embodiment, the mask is circular in shape. When the pupil is constricted, light enters the retina through the pinhole-like aperture. When the pupil is dilated, light enters the retina through the pinhole-like aperture and the outer edges of the mask.
In addition, U.S. Pat. No. 3,794,414 (“the '414 patent”) discloses a contact lens with a pinhole-like aperture. In the '414 patent, the mask forming the pinhole-like aperture has radial slits and/or scalloped edges. In addition, the mask forming the pinhole-like aperture is two spaced-apart concentric circles. However, the radial slits, scalloped edges and two spaced-apart concentric circles promote light diffraction, which in turn reduces the contrast of the image.
In U.S. Pat. Nos. 4,955,904, 5,245,367, 5,757,458 and 5,786,883, various modifications to an ophthalmic lens with a pinhole-like aperture are disclosed. For example, the patents disclose use of an optical power for vision correction in the pinhole-like aperture, or use of an optical power for vision correction in the area outside the mask. In contrast, in U.S. Pat. No. 5,980,040, the mask is powered. In particular, the mask is powered to bend the light passing through the mask to impinge on the retina at a radial distance outside of the fovea. In other words, the mask is powered to “defocus” the light.
In each of these patents, the mask forming the pinhole-like aperture is made, in whole or in part, of a light absorptive material. A light-absorptive material is a material in which light is lost as it passes through the material, generally due to conversion of the light into another form of energy, e.g., heat.
In accordance with an embodiment of the invention, an ophthalmic lens comprises a lens body, an optic located in the lens body, the optic configured to produce light interference, and a pinhole-like optical aperture substantially in the center of the optic. In a further embodiment of the invention, the optic is configured to positively interfere with parallel light reaching the optic and negatively interfere with diverging light reaching the optic. In addition, some diverging light may pass through the optic. In this alternate embodiment of the invention, the optic is configured to spread out the diverging light passing through the optic.
In an alternate embodiment of the invention, an ophthalmic lens comprises a lens body, an optic located in the lens body, the optic configured to produce light scattering, and a pinhole-like optical aperture substantially in the center of the optic. In a further embodiment of the invention, the optic is configured to forward scatter parallel light reaching the optic and back scatter diverging light reaching the optic.
In another alternative embodiment of the invention, an ophthalmic lens comprises a lens body, an optic located in the lens body, the optic configured to produce light reflection, and a pinhole-like optical aperture substantially in the center of the optic. In an alternate embodiment of the invention, the optic is composed, in whole or in part, of a light reflective material.
In further embodiments of the inventions, the optic may be configured as a series of concentric circles, a weave, a pattern of particles, or a pattern of curvatures. In addition, the pinhole-like aperture includes an optical power for vision correction, and may have a diameter in the range of substantially 0.05 mm to substantially 5.0 mm. Further, the optic may have an outer diameter in the range of substantially 1.0 mm to substantially 8.0 mm. The optic may also be composed of a material having varying degrees of opacity, and the ophthalmic lens and the optic may be composed of a bio-compatible, non-dissolving material, such as polymethyl methacrylate or a medical polymer.
In accordance with another embodiment of the invention, a method for screening a patient for an ophthalmic lens, the ophthalmic lens having a pinhole-like optical aperture, comprises fitting each of the patient's eyes with a first contact lens, placing a mask on each of the first contact lens, the mask configured to produce a pinhole-like aperture in each of the first contact lens, fitting each of the patient's eyes with a second contact lens, the second contact lens being placed over the mask to hold the mask in a substantially constant position, and testing the patient's vision.
In further embodiments of the invention, the mask may be a light interference mask, a light scattering mask, or a light reflective mask. The first contact lens may include an optical power for vision correction. In addition, each of the first and second contact lenses may be soft contact lenses. Further, the mask for each of the patient's eyes may have a light absorption of substantially 100%. In the alternative, the mask for each of the patient's eyes may be composed of a polarized material.
In still further embodiments of the invention, the process of testing comprises testing the patient's acuity for distance vision under bright and dim lighting conditions, testing the patient's acuity for near vision under bright and dim lighting conditions, and testing the patient's contrast sensitivity under bright and dim lighting conditions. The process of testing may further comprise testing a patient's visual acuity using a night driving simulation. The night driving simulation may include a series of objects and road signs under bright and dim lighting conditions, as well as having the patient face a simulated oncoming automobile headlight.
In an alternate embodiment of the invention, the process of testing comprises replacing the mask in one of the patient's eyes with a mask having a light absorption of substantially 85% or less, then, if needed, replacing the mask in the patient's other eye with a mask having a light absorption of substantially 85% or less. Further, the process of testing comprises, if needed, removing the mask from one of the patient's eyes.
In another alternate embodiment of the invention, the process of testing comprises placing an analyzer in the spectacle plane of one of the patient's eyes, the analyzer including a polarizing element, rotating the polarizing element to achieve an optimal balance of contrast and brightness, and determining the resultant light absorption of the mask. In addition, the process of testing may include evaluating the cosmetic appearance of the mask.
In accordance with a still another embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises removing the epithelial sheet, creating a depression in the Bowman's membrane, the depression being of sufficient depth and width to expose the top layer of the stroma and accommodate the mask, placing the mask in the depression, and placing the removed epithelial sheet over the mask. In a further embodiment of the invention, the depression may extend into the top layer of the stroma.
In an alternate embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises hinging open a portion of the Bowman's membrane, creating a depression in the top layer of the stroma, the depression being of sufficient depth and width to accommodate the mask, placing the mask in the depression, and placing the hinged Bowman's membrane over the mask.
In another alternate embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises creating a channel in the top layer of the stroma, the channel being in a plane parallel to the cornea's surface, and placing the mask in the channel. In this embodiment, the mask may be threaded into the channel, or the mask may be injected into the channel.
In still another alternate embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises penetrating the top layer of the stroma with an injecting device, and injecting the mask into the top layer of the stroma with the injecting device. In this embodiment, the injecting device may be a ring of needles. In addition, the mask may be a pigment, or the mask may be composed of pieces of pigmented material suspended in a bio-compatible medium. The pigmented material may be made of a medical polymer, e.g., suture material.
In one other alternate embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises hinging open a corneal flap, the corneal flap comprising substantially the outermost 20% of the cornea, placing the mask on the cornea, and placing the hinged corneal flap over the mask.
In still one other alternate embodiment of the invention, a method for implanting a mask in a cornea, the mask configured to increase the depth of focus of the human eye, comprises creating a pocket in the stroma, the pocket being of sufficient size to accommodate the mask, and-placing the mask in the created pocket.
In further embodiments of the inventions, the mask may be a light interference optic, a light scattering optic, or a light reflective optic. In addition, the mask may block visual aberrations. In addition, after surgery, a contact lens may be placed over at least the affected portion of the cornea.
The foregoing and other objects and advantages of the invention will be appreciated more fully from the following further description thereof with reference to the accompanying drawings wherein:
a and 1b show an exemplary ophthalmic lens with an exemplary optic configured to produce light interference.
a and 2b show another exemplary ophthalmic lens with another exemplary optic configured to produce light interference.
a and 3b show an exemplary ophthalmic lens with an exemplary optic configured to produce light scattering.
a and 4b show an exemplary ophthalmic lens with an exemplary optic configured to produce light reflection.
a through 6c show a mask, configured to increase the depth of focus of the human eye, inserted underneath the cornea's epithelium sheet.
a through 7c show a mask, configured to increase the depth of focus of the human eye, inserted beneath the cornea's Bowman's membrane.
In accordance with an embodiment of the invention, an ophthalmic lens (e.g., a contact lens, an intraocular lens, a corneal inlay lens, etc.) increases the depth of focus of the human eye through the use of an optic. The optic surrounds a pinhole-like optical aperture near the optical center of the lens. The pinhole-like aperture in conjunction with the optic increases the depth of focus of the human eye. In particular, the optic increases the depth of focus of the human eye using light interference, light scattering, light reflection, light absorption and/or a combination of one or more of these properties. An optic configured in accordance with the various embodiments of the invention is referred to as a Paraxial Adaptive Optic™.
a and 1b show an exemplary ophthalmic lens with an exemplary optic configured to produce light interference.
Light interference is the additive process in which the amplitude of two or more overlapping light waves is either attenuated or reinforced. For example, when two overlapping light waves are in-phase (the crest and trough of one wave coincides with the crest and trough of the other wave), then the amplitude of the resultant light wave is reinforced. This type of interference is referred to as positive interference. In contrast, when two overlapping light waves are out-of-phase (the crest of one wave coincides with the trough of the other wave), then the amplitude of the resultant light wave is attenuated. This type of interference is referred to as negative interference. Of course, light interference also occurs between the two extremes of in-phase and out-of-phase.
As shown in
In operation, optical aperture 120 increases the depth of focus of the human eye via a “pinhole effect.” In particular, optical aperture 120 increases depth of focus by limiting the light reaching the retina to plane wavefront light. In photonics, a wavefront is a surface connecting all points equidistant from a source. Plane wavefront light is relatively parallel light, e.g., light from a distant source. It is “relatively” parallel light because, in reality, even light from a distant star is diverging light. In contrast, convex wavefront light is relatively diverging light, e.g., light from a near source. It is easier for the human eye to focus plane wavefront light because the crystalline lens of the human eye can focus parallel light on the retina with little or no accommodation. In accommodation, the crystalline lens, through the action of the ciliary muscles, thickens and, thereby, changes its degree of curvature.
In order to achieve a useful “pinhole effect,” optical aperture 120 should have a diameter in the range of substantially 0.05 millimeters (“mm”) to substantially 5.0 mm. In addition, in order to aid examination of the retina and increase brightness when the pupil is dilated, the outer diameter of optic 100 should be in the range of substantially 1.0 mm to substantially 8.0 mm. Moreover, to further improve vision, optical aperture 120 may include an optical power for vision correction, e.g., correction for near vision, correction for distance vision, correction for intermediate vision, etc. Also, the area outside optic 100 may include an optical power for vision correction.
In operation, optic 100 increases the depth of focus of the human eye via its configuration. In particular, optic 100 is configured to produce light interference via a series of concentric circles. Specifically, optic 100 is configured to reinforce relatively parallel light and attenuate relatively diverging light. When optic 100 attenuates less than all of the relatively diverging light, then optic 100 is further configured to spread out the diverging light that passes through optic 100, i.e., weakening the diverging light passing through optic 100. Thus, because diverging light is attenuated and/or weakened, the “pinhole effect” of optical aperture 120 is increased for relatively near objects, producing a higher contrast depth of focus image of relatively near objects. Moreover, because parallel light is reinforced, the “pinhole effect” of optical aperture 120 is reduced, producing a brighter image of relatively distant objects.
Optic 100 is also configured to effect the chromatic aberration of the human eye. The human eye's chromatic aberration, in which the size of an image appears to change when the color of the image is changed, results from the normal increase in refractive index toward the blue end of the color spectrum. In optic 100, the increase in refractive index is toward the red end of the color spectrum. Thus, optic 100 may reduce or cancel the chromatic aberration of the human eye.
Further, optic 100 is configured to meet the specific needs of the patient. For example, a person of skill in the art understands that, among other things, the addition of concentric circles, the removal of concentric circles, the change in spacing between concentric circles, the varying of spacing between concentric circles, and the shape of the concentric circles (e.g., oval, round, elliptical, etc.) would influence the light interference properties of optic 100.
a and 2b show another exemplary ophthalmic lens with another exemplary optic configured to produce light interference. In this exemplary embodiment, optic 200 is configured to produce light interference via a weave. As discussed in regard to optic 100, the weave reinforces relatively parallel light and attenuates relatively diverging light. Depending on the weave's material, the weave may also absorb light coming into contact with the weave's material.
As discussed in regard to optic 100, optic 200 is configured to meet the specific needs of the patient. For example, a person of skill in the art understands that, among other things, the density of the weave would influence the light interference properties of optic 200.
a and 3b show an exemplary ophthalmic lens with an exemplary optic configured to produce light scattering.
In general, light scattering is the deflection of light upon interaction with a medium. Light is forward scattered when, upon interaction with a medium, it is deflected through angles of 90°, or less with respect to the original direction of motion. Light is back scattered when, upon interaction with a medium, it is deflected through angles in excess of 90°. with respect to the original direction of motion.
As shown in
As discussed in regard to optical apertures 120 and 220, optical aperture 320 increases the depth of focus of the human eye via a “pinhole effect.” Similarly, as discussed in regard to optics 100 and 200, optic 300 increases the depth of focus of the human eye via its configuration. In particular, optic 300 is configured to produce light scattering via a pattern of particles. Specifically, optic 300 is configured to forward scatter relatively parallel light and back scatter relatively diverging light. Thus, because diverging light is back scattered, the “pinhole effect” of optical aperture 320 is increased for relatively near objects, producing a higher contrast depth of focus image of relatively near objects. Moreover, because parallel light is forward scattered, the “pinhole effect” of optical aperture 320 is reduced, producing a brighter image of relatively distant objects.
Further, optic 300 is configured to meet the specific needs of the patient. For example, a person of skill in the art understands that, among other things, the light absorption of the particles, the index of refraction of the particles, the index of refraction of the media surrounding the particles, the size of the particles, and the space between the particles would influence the light scattering properties of optic 300. In addition, optic 300 may be configured to produce light interference, as discussed in regard to optics 100 and 200.
a and 4b show an exemplary ophthalmic lens with an exemplary optic configured to produce light reflection.
Optic 400 is located substantially in the center of lens body 410. Optic 400 surrounds optical aperture 420 located near the optical center of lens body 410. The specific location of optical aperture 420 in lens body 410 varies in accordance with the patient's eye. Specifically, optical aperture 420 is positioned in lens body 410 to be concentric with the patient's pupil.
As discussed in regard to optical apertures 120, 220 and 320, optical aperture 420 increases the depth of focus of the human eye via a “pinhole effect.” Similarly, as discussed in regard to optics 100, 200 and 300, optic 400 increases the depth of focus of the human eye via its configuration. In particular, optic 400 is configured to reflect light, in whole or in part, via a pattern of curvatures. Specifically, optic 400 is configured to favor transmission of the light to which the retinal rods are more sensitive, i.e., dim light and/or blue light, and to block the light to which retinal cones are more sensitive, i.e., bright light Thus, because bright light is blocked, the “pinhole effect” of optical aperture 420 is increased for relatively near objects, producing a higher contrast depth of focus image of relatively near objects. Moreover, because dim light and/or blue light is transmitted, the “pinhole effect” of optical aperture 420 is reduced, producing a brighter image of relatively distant objects.
In an alternate embodiment, optic 400 may be composed, in whole or in part, of a light reflective material. A light reflective material is a material that, in whole or in part, reflects back light coming into contact with the material.
Further, optic 400 may be configured to meet the specific needs of the patient. For example, a person of skill in the art understands that, among other things, the type of material, the thickness of material, and the curvature of material would influence the light reflective properties of optic 400. In addition, optic 400 may be configured to produce light interference and/or light scattering, as discussed in regard to optics 100, 200 and 300, respectively.
In a particular embodiment of the ophthalmic lens described in
Further, this particular embodiment of optic 400 may be configured to meet the specific needs of the patient. For example, a person of skill in the art understands that, among other things, the peak transmission of the mask may be changed, e.g., to a peak transmission of 500 nm. In addition, the mask may be composed of material, other than light reflective material, which also allows the desired peak transmissions.
In alternate embodiments, the optic is composed of bio-compatible, non-dissolving material, e.g., polymethyl methacrylate or medical polymers. In addition, the optic may be composed, in whole or in part, of a light reflective material or, in whole or in part, of a light absorptive material Further, the optic may be composed, in whole or in part, of a material having varying degrees of opacity. The optic may also be configured to produce light interference, light-scattering and light reflection, or some combination of one or more of these properties. Moreover, the optic may be colored to match the color of a patient's iris.
In accordance with a further embodiment of the invention, a patient interested in an ophthalmic lens with a pinhole-like aperture is screened using soft contact lenses and a mask, referred to as a pinhole screening device. The mask may be an optic as described in the prior art, an optic as described herein, or an optic combining one or more of these properties. After insertion of the pinhole screening device, the patient's vision is tested.
A test of the patient's vision may include testing the patient's acuity for distance vision under bright and dim lighting conditions, testing the patient's acuity for near vision under bright and dim lighting conditions, and testing the patient's contrast sensitivity under bright and dim lighting conditions. In addition, the test may include testing the patient's visual acuity using a night driving simulation. A night driving simulation may include a series of objects and road signs under bright and dim lighting conditions, as well as a simulated oncoming automobile headlight.
The test of the patient's vision may further include changing the mask. For example, the test might first be conducted using, in each of the patient's eyes, a mask having a light absorption of substantially 100%. If, for example, the patient experiences a sense of dimness, the mask in one of the patient's eyes may be replaced with a mask having a light absorption of substantially 85%. If, for example, the sense of dimness continues, the mask in the patient's other eye may be replaced with a mask having a light absorption of substantially 85%. Then, for example, if the sense of dimness continues, the mask may be removed from one of the patient's eyes.
In the alternate, the mask in one of the patient's eyes may be replaced with a mask having a light absorption less than substantially 85%. If, for example, the patient experiences a sense of dimness with a mask having a light absorption of substantially 100%, then the mask in one of the patient's eyes may be replaced with a mask having a light absorption of substantially 75%. If, for example, the sense of dimness continues, the mask in the patient's other eye may be replaced with a mask having a light absorption of substantially 75%. Then, for example, if the sense of dimness continues, the 75% mask may be replaced with a mask having a light absorption of substantially 50%.
As can be seen, there are numerous permutations for thoroughly screening the patient to find the optimal balance of contrast and brightness. In effect, the, mask in each of the patient's eyes is replaced, every other time, with a mask having a different light absorption than the replaced mask. This process continues until the optimal balance of contrast and brightness is found.
The process for changing the mask while testing the patient's vision also includes changing from an optic as described in the prior art to an optic as described herein. In addition, various mask configurations may be used. For example, an optic having both light interference and light scattering may be used, or an optic having both light reflective and light absorptive properties may be used. Once again, the numerous permutations allow for thoroughly screening the patient to find the optimal balance of contrast and brightness prior to, for example, the doctor placing a customized order or the patient undergoing invasive surgery.
The test of the patient's vision may also include evaluating the cosmetic appearance of the mask. For example, if the patient is dissatisfied with the appearance of the mask, the mask can be replaced with a mask of appropriate configuration colored to match the patient's iris.
In an alternate testing process, the mask placed on the soft contact lens in each of the patient's eyes is composed of a polarized material A polarized material has a light absorption of substantially 50%. Then, an analyzer, which contains a polarized element, is used to help calculate the patient's optimal light absorption properties for the mask. In the process, the analyzer is placed in the spectacle plane of one of the patient's eyes and the polarized element in the analyzer is rotated until the patient experiences an optimal balance of contrast and brightness. The process may be repeated for the patient's other eye.
Using the analyzer, the doctor may now calculate the resultant light absorption of the mask. If desired, a mask of similar light absorption, whether it be an optic as described in the prior art, an optic as described herein, or an optic combining one or more of these properties, can now be placed between the contact lenses in each of the patient's eyes and the patient's vision tested, as described above.
In accordance with a still further embodiment of the invention, a mask is surgically implanted into the eye of a patient interested in increasing his or her depth of focus. For example, the patient may suffer from presbyopia, a condition in which the crystalline lens can no longer accommodate near vision because of a loss of elasticity in the lens or a weakness in the ciliary muscle. The mask may be an optic as described in the prior art, an optic as described herein, or an optic combining one or more of these properties. Further, the mask may be configured to correct visual aberrations. To aid the surgeon surgically implanting a mask into a patient's eye, the mask may be pre-rolled or folded for ease of implantation.
The mask may be implanted in several locations. For example, the mask may be implanted underneath the cornea's epithelium sheet, beneath the cornea's Bowman membrane, in the top layer of the cornea's stroma, or in the cornea's stroma. When the mask is placed underneath the cornea's epithelium sheet, removal of the mask requires little more than removal of the cornea's epithelium sheet.
a through 6c show mask 600 inserted underneath epithelium sheet 610. In this embodiment, the surgeon first removes epithelium sheet 610. For example, as shown in
a through 7c show mask 700 inserted beneath Bowman's membrane 720. In this embodiment, as shown in
In an alternate embodiment, a mask of sufficient thinness, i.e., less than substantially 20 microns, may be placed underneath epithelium sheet 610, or beneath Bowman's member 720, without creating a depression in the top layer of the stroma.
In an alternate method for surgically implanting a mask in the eye of a patient, the mask may be threaded into a channel created in the top layer of the stroma. In this method, a curved channeling tool creates a channel in the top layer of the stroma, the channel being in a plane parallel to the surface of the cornea. The channeling tool either pierces the surface of the cornea or, in the alternative, is inserted via a small superficial radial incision. In the alternative, a laser focusing an ablative beam may create the channel in the top layer of the stroma. In this embodiment, the mask may be a single segment with a break, or it may be two or more segments.
In another alternate method for surgically implanting a mask in the eye of a patient, the mask may be injected into the top layer of the stroma. In this embodiment, an injection tool with a stop penetrates the surface of the cornea to the specified depth. For example, the injection tool may be a ring of needles capable of producing a mask with a single injection. In the alternative, a channel may first be created in the top layer of the stroma. Then, the injector tool may inject the mask into the tunnel. In this embodiment, the mask may be a pigment, or it may be pieces of pigmented material suspended in a bio-compatible medium. The pigment material may be made of a polymer or, in the alternative, made of a suture material.
In still another alternate method for surgically implanting a mask in the eye of a patient, the mask may be placed beneath the corneal flap created during keratectomy, when the outermost 20% of the cornea is hinged open.
In one still other alternate method for surgically implanting a mask in the eye of a patient, the mask may be placed in a pocket created in the cornea's stroma.
Although various exemplary embodiments of the invention have been disclosed, it should be apparent to those skilled in the art that various changes and modifications can be made which will achieve some of the advantages of the invention without departing from the true scope of the invention. These and other obvious modifications are intended to be covered by the appended claims.
This application is a continuation of U.S. patent application Ser. No. 12/182,056, filed Jul. 29, 2008, now U.S. Pat. No. 8,343,215,which is a divisional application of U.S. patent application Ser. No. 11/284,791, filed Nov. 22, 2005, now U.S. Pat. No. 7,404,638, which is a divisional application of U.S. patent application Ser. No. 10/729,200, filed Dec. 5, 2003, now U.S. Pat. No. 6,966,648, which is a divisional of U.S. patent application Ser. No. 10/384,957, filed Mar. 10, 2003, now U.S. Pat. No. 6,874,886, which is a divisional of U.S. patent application Ser. No. 09/516,258, filed Feb. 29, 2000, now U.S. Pat. No. 6,554,424, which claimed priority from provisional U.S. Patent Application Ser. No. 60/122,001, filed Mar. 1, 1999, entitled “SCREENING TECHNIQUES AND DEVICES USED PRIOR TO THE INSERTION OF A CORNEAL ANNULUS INLAY;” provisional U.S. Patent Application Ser. No. 60/124,345, filed Mar. 15, 1999, entitled “NEW METHOD OF INCREASING THE DEPTH OF FOCUS OF THE HUMAN EYE;” and provisional U.S. patent application Ser. No. 60/138,110, filed Jun. 7, 1999, entitled “WOVEN ANNULAR MASK CORNEAL INLAY.” U.S. patent application Ser. No. 12/182,056 is also a divisional application of U.S. patent application Ser. No. 09/516,258, filed Feb. 29, 2000, now U.S. Pat. No. 6,554,424. The disclosures of all these applications are incorporated herein, in their entirety, by reference.
Number | Name | Date | Kind |
---|---|---|---|
564518 | Heilborn | Jul 1896 | A |
1034516 | Samberg | Aug 1912 | A |
1206132 | Otte | Nov 1916 | A |
1959915 | Guthrie | May 1934 | A |
2129305 | Feinbloom | Sep 1938 | A |
2470927 | Hale, Jr. | May 1949 | A |
2714721 | Stone, Jr. | Aug 1955 | A |
3034403 | Neefe | May 1962 | A |
3074407 | Moon et al. | Jan 1963 | A |
3270099 | Camp | Aug 1966 | A |
3339997 | Wesley | Sep 1967 | A |
D212868 | Olson | Dec 1968 | S |
3458870 | Stone, Jr. | Aug 1969 | A |
3507566 | Knapp | Apr 1970 | A |
3536386 | Spivack | Oct 1970 | A |
3578850 | Grant | May 1971 | A |
3600098 | Mohrman | Aug 1971 | A |
3726587 | Kendall | Apr 1973 | A |
3776230 | Neefe | Dec 1973 | A |
3794414 | Wesley | Feb 1974 | A |
3852032 | Urbach | Dec 1974 | A |
3877502 | Hunckler | Apr 1975 | A |
3914013 | Rosenberg | Oct 1975 | A |
3946982 | Calkins et al. | Mar 1976 | A |
3982541 | L'Esperance, Jr. | Sep 1976 | A |
4010496 | Neefe | Mar 1977 | A |
4073015 | Peyman | Feb 1978 | A |
3392727 | Hanlon | Jul 1978 | A |
4099529 | Peyman | Jul 1978 | A |
4138191 | Peyman | Feb 1979 | A |
4191195 | Miller | Mar 1980 | A |
4210391 | Cohen | Jul 1980 | A |
4272191 | Bergkvist | Jun 1981 | A |
4298004 | Schchar et al. | Nov 1981 | A |
4312575 | Peyman et al. | Jan 1982 | A |
4340283 | Cohen | Jul 1982 | A |
4367949 | Lavering | Jan 1983 | A |
4383843 | Iyenger | May 1983 | A |
4402579 | Poler | Sep 1983 | A |
4402681 | Haas et al. | Sep 1983 | A |
4409979 | Roussel et al. | Oct 1983 | A |
4423728 | Lieberman | Jan 1984 | A |
4445892 | Hussein et al. | May 1984 | A |
4450593 | Poler | May 1984 | A |
4452235 | Reynolds | Jun 1984 | A |
4461294 | Baron | Jul 1984 | A |
4469098 | Daui | Sep 1984 | A |
4485499 | Castleman | Dec 1984 | A |
4505855 | Bruns et al. | Mar 1985 | A |
4528311 | Beard et al. | Jul 1985 | A |
4536240 | Winn | Aug 1985 | A |
4538608 | L'Esperance, Jr. | Sep 1985 | A |
4547914 | Castleman | Oct 1985 | A |
4547915 | Castleman | Oct 1985 | A |
4563565 | Kampfer et al. | Jan 1986 | A |
4573998 | Mazzocco | Mar 1986 | A |
4575373 | Johnson | Mar 1986 | A |
4575915 | Clark et al. | Mar 1986 | A |
4576453 | Borowsky | Mar 1986 | A |
4582402 | Knapp | Apr 1986 | A |
4607617 | Choyce | Aug 1986 | A |
4612012 | White | Sep 1986 | A |
4615702 | Koziol et al. | Oct 1986 | A |
4617023 | Peyman | Oct 1986 | A |
4624669 | Grendahl | Nov 1986 | A |
4633866 | Peyman et al. | Jan 1987 | A |
4636049 | Blaker | Jan 1987 | A |
4636211 | Nielsen et al. | Jan 1987 | A |
4636212 | Posin et al. | Jan 1987 | A |
4637697 | Freeman | Jan 1987 | A |
4639105 | Neefe | Jan 1987 | A |
4641934 | Freeman | Feb 1987 | A |
4642112 | Freeman | Feb 1987 | A |
4646720 | Peyman et al. | Mar 1987 | A |
4648400 | Schneider et al. | Mar 1987 | A |
4655774 | Choyce | Apr 1987 | A |
4662370 | Hoffmann et al. | May 1987 | A |
4665913 | L'Esperance, Jr. | May 1987 | A |
4666249 | Bauman et al. | May 1987 | A |
4666446 | Koziol et al. | May 1987 | A |
4669466 | L'Esperance, Jr. | Jun 1987 | A |
4669834 | Richter | Jun 1987 | A |
4672021 | Blumel et al. | Jun 1987 | A |
4674503 | Peyman et al. | Jun 1987 | A |
4676790 | Kern | Jun 1987 | A |
4676791 | Le Master et al. | Jun 1987 | A |
4678422 | York | Jul 1987 | A |
4685921 | Peyman | Aug 1987 | A |
4685922 | Peyman | Aug 1987 | A |
4701038 | Neefe | Oct 1987 | A |
4702574 | Bawa | Oct 1987 | A |
4702865 | Koziol et al. | Oct 1987 | A |
4704016 | de Carle | Nov 1987 | A |
4710003 | Masuda et al. | Dec 1987 | A |
4713446 | DeVore et al. | Dec 1987 | A |
4715858 | Lindstrom | Dec 1987 | A |
4718418 | L'Esperance | Jan 1988 | A |
4729372 | L'Esperance, Jr. | Mar 1988 | A |
4729373 | Peyman | Mar 1988 | A |
4732148 | L'Esperance, Jr. | Mar 1988 | A |
4744360 | Bath | May 1988 | A |
4753654 | Posin et al. | Jun 1988 | A |
4779973 | Miller et al. | Oct 1988 | A |
4785796 | Mattson | Nov 1988 | A |
4785810 | Baccala et al. | Nov 1988 | A |
4787903 | Grendahl | Nov 1988 | A |
4795462 | Grendahl | Jan 1989 | A |
4796623 | Krasner et al. | Jan 1989 | A |
4798608 | Grendahl | Jan 1989 | A |
4799478 | Fedorov et al. | Jan 1989 | A |
4799784 | Safir | Jan 1989 | A |
4799931 | Lindstrom | Jan 1989 | A |
4806382 | Goldberg et al. | Feb 1989 | A |
4807623 | Lieberman | Feb 1989 | A |
4808181 | Kelman | Feb 1989 | A |
4813955 | Achatz et al. | Mar 1989 | A |
4814050 | McGraw et al. | Mar 1989 | A |
4838266 | Koziol et al. | Jun 1989 | A |
4840175 | Peyman | Jun 1989 | A |
4842599 | Bronstein | Jun 1989 | A |
4849323 | Endo et al. | Jul 1989 | A |
4851003 | Lindstrom | Jul 1989 | A |
4863466 | Schlegel | Sep 1989 | A |
4865601 | Caldwell et al. | Sep 1989 | A |
4869587 | Breger | Sep 1989 | A |
4878910 | Koziol et al. | Nov 1989 | A |
4881860 | Kanazawa | Nov 1989 | A |
4881954 | Bikson et al. | Nov 1989 | A |
4889795 | Kaifu et al. | Dec 1989 | A |
4890913 | De Carle | Jan 1990 | A |
4891043 | Zeimer et al. | Jan 1990 | A |
4892543 | Turley | Jan 1990 | A |
4898461 | Portney | Feb 1990 | A |
4903695 | Warner et al. | Feb 1990 | A |
4907586 | Bille et al. | Mar 1990 | A |
4923297 | Arndt | May 1990 | A |
4932970 | Portney | Jun 1990 | A |
4955904 | Atebara et al. | Sep 1990 | A |
4958922 | Binh et al. | Sep 1990 | A |
4959070 | McDonald | Sep 1990 | A |
4961744 | Kilmer et al. | Oct 1990 | A |
4965545 | Johnson | Oct 1990 | A |
4971432 | Koeniger | Nov 1990 | A |
4976709 | Sand | Dec 1990 | A |
4976732 | Vorosmarthy | Dec 1990 | A |
4983181 | Civerchia | Jan 1991 | A |
4985559 | Goldberg et al. | Jan 1991 | A |
4990165 | Bikson et al. | Feb 1991 | A |
4994058 | Raven et al. | Feb 1991 | A |
4994080 | Shepard | Feb 1991 | A |
4997268 | Dauvergne | Mar 1991 | A |
5002571 | O'Donnel, Jr. | Mar 1991 | A |
5013319 | Davis | May 1991 | A |
5019097 | Knight et al. | May 1991 | A |
5026393 | Mackool | Jun 1991 | A |
D318117 | Michelson | Jul 1991 | S |
5030230 | White | Jul 1991 | A |
5041133 | Sayano et al. | Aug 1991 | A |
5061914 | Busch et al. | Oct 1991 | A |
5063942 | Kilmer et al. | Nov 1991 | A |
5065516 | Dulebohn | Nov 1991 | A |
5067961 | Kelman et al. | Nov 1991 | A |
5076684 | Simpson et al. | Dec 1991 | A |
D323891 | Arkel | Feb 1992 | S |
5089022 | Koester et al. | Feb 1992 | A |
5089024 | Christie et al. | Feb 1992 | A |
5090955 | Simon | Feb 1992 | A |
5092874 | Rogers | Mar 1992 | A |
5094521 | Jolson et al. | Mar 1992 | A |
5098443 | Parel et al. | Mar 1992 | A |
5098444 | Feaster | Mar 1992 | A |
D325500 | Dennis | Apr 1992 | S |
5104957 | Kelman et al. | Apr 1992 | A |
5108169 | Mandell | Apr 1992 | A |
5108428 | Capecchi et al. | Apr 1992 | A |
5112328 | Taboada et al. | May 1992 | A |
5112350 | Civerchia et al. | May 1992 | A |
5116111 | Simpson et al. | May 1992 | A |
5119555 | Johnson | Jun 1992 | A |
5120120 | Cohen | Jun 1992 | A |
5120121 | Rawlings et al. | Jun 1992 | A |
5123921 | Werblin et al. | Jun 1992 | A |
5133745 | Falcetta et al. | Jul 1992 | A |
5139518 | White | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5151098 | Loertascher | Sep 1992 | A |
5152789 | Willis | Oct 1992 | A |
5156622 | Thompson | Oct 1992 | A |
5158572 | Nielsen | Oct 1992 | A |
5160463 | Evans et al. | Nov 1992 | A |
5165897 | Johnson | Nov 1992 | A |
5166712 | Portney | Nov 1992 | A |
5171318 | Gibson et al. | Dec 1992 | A |
5172143 | Baude et al. | Dec 1992 | A |
5185152 | Peyman | Feb 1993 | A |
5188125 | Kilmer et al. | Feb 1993 | A |
5188494 | Hatin | Feb 1993 | A |
5192316 | Ting | Mar 1993 | A |
5192318 | Schneider et al. | Mar 1993 | A |
5196026 | Barrett et al. | Mar 1993 | A |
5196027 | Thompson et al. | Mar 1993 | A |
5201762 | Hauber | Apr 1993 | A |
5203865 | Siepser | Apr 1993 | A |
5215104 | Steinert | Jun 1993 | A |
5219844 | Peyman et al. | Jun 1993 | A |
5225858 | Portney | Jul 1993 | A |
5239066 | Falkow et al. | Aug 1993 | A |
5245367 | Miller et al. | Sep 1993 | A |
5245738 | Johnson | Sep 1993 | A |
5258412 | Peyman et al. | Nov 1993 | A |
5260727 | Oksman et al. | Nov 1993 | A |
5261997 | Inselmann | Nov 1993 | A |
5269795 | Arnott | Dec 1993 | A |
5269812 | White | Dec 1993 | A |
5270744 | Portney | Dec 1993 | A |
5274404 | Michael | Dec 1993 | A |
5282971 | Degen et al. | Feb 1994 | A |
5288293 | O'Donnell, Jr. | Feb 1994 | A |
5288436 | Liu et al. | Feb 1994 | A |
5290301 | Lieberman | Mar 1994 | A |
5292514 | Capecchi et al. | Mar 1994 | A |
5296305 | Baude et al. | Mar 1994 | A |
5296881 | Freeman | Mar 1994 | A |
D345796 | Pernicka | Apr 1994 | S |
5300116 | Chirila et al. | Apr 1994 | A |
5300118 | Silvestrini et al. | Apr 1994 | A |
5302978 | Evans et al. | Apr 1994 | A |
5306297 | Rheinish et al. | Apr 1994 | A |
5310654 | Isberg et al. | May 1994 | A |
5312330 | Klopotek | May 1994 | A |
5312393 | Mastel | May 1994 | A |
5312424 | Kilmer et al. | May 1994 | A |
5314439 | Sugita | May 1994 | A |
5314961 | Anton et al. | May 1994 | A |
5315344 | Clark et al. | May 1994 | A |
5318044 | Kilmer et al. | Jun 1994 | A |
5318047 | Davenport et al. | Jun 1994 | A |
5322649 | Rheinish et al. | Jun 1994 | A |
5323788 | Silvestrini et al. | Jun 1994 | A |
5325880 | Johnson et al. | Jul 1994 | A |
5332802 | Kelman et al. | Jul 1994 | A |
5336261 | Barrett et al. | Aug 1994 | A |
5346689 | Peyman et al. | Sep 1994 | A |
5354331 | Schachar | Oct 1994 | A |
5358520 | Patel | Oct 1994 | A |
5366499 | Py | Nov 1994 | A |
5368604 | Kilmer et al. | Nov 1994 | A |
5372580 | Simon et al. | Dec 1994 | A |
5374272 | Arpa et al. | Dec 1994 | A |
D354566 | Donahoo | Jan 1995 | S |
5391201 | Barret et al. | Feb 1995 | A |
5401508 | Manesis | Mar 1995 | A |
5403335 | Loomas et al. | Apr 1995 | A |
5405384 | Silvestrini | Apr 1995 | A |
5414477 | Jahnke | May 1995 | A |
5422424 | Selsted et al. | Jun 1995 | A |
5433745 | Graham et al. | Jul 1995 | A |
5434630 | Bransome | Jul 1995 | A |
5437274 | Khoobehl et al. | Aug 1995 | A |
5441511 | Hanna | Aug 1995 | A |
5458819 | Chirila et al. | Oct 1995 | A |
5466260 | Silvestrini et al. | Nov 1995 | A |
5474548 | Knopp et al. | Dec 1995 | A |
5475452 | Kuhn et al. | Dec 1995 | A |
5476515 | Kelman et al. | Dec 1995 | A |
5480427 | Kelman et al. | Jan 1996 | A |
5489300 | Capecchi et al. | Feb 1996 | A |
5496339 | Koepnick | Mar 1996 | A |
5505722 | Kilmer et al. | Apr 1996 | A |
5505723 | Muller | Apr 1996 | A |
5507740 | O'Donnel, Jr. | Apr 1996 | A |
5507741 | L'Esperance, Jr. | Apr 1996 | A |
5507759 | Nordan | Apr 1996 | A |
5509922 | Aranyi et al. | Apr 1996 | A |
5516467 | Niwa et al. | May 1996 | A |
5516522 | Peyman et al. | May 1996 | A |
5522888 | Civerchia | Jun 1996 | A |
5526178 | Goldstein et al. | Jun 1996 | A |
5527356 | Peyman et al. | Jun 1996 | A |
5527524 | Tomalia et al. | Jun 1996 | A |
5547468 | Simon et al. | Aug 1996 | A |
5547473 | Peyman | Aug 1996 | A |
5567365 | Weinschenk, III et al. | Oct 1996 | A |
D375245 | Irving | Nov 1996 | S |
5571177 | Deacon et al. | Nov 1996 | A |
5579063 | Magnante et al. | Nov 1996 | A |
RE35421 | Ruiz et al. | Jan 1997 | E |
5591185 | Kilmer et al. | Jan 1997 | A |
5592246 | Kuhn et al. | Jan 1997 | A |
5599341 | Mathis et al. | Feb 1997 | A |
5599537 | Miller, III et al. | Feb 1997 | A |
5605938 | Roufa et al. | Feb 1997 | A |
5607437 | Simon et al. | Mar 1997 | A |
5607472 | Thompson | Mar 1997 | A |
5608471 | Miller | Mar 1997 | A |
5610719 | Allen et al. | Mar 1997 | A |
5624456 | Hellenkamp | Apr 1997 | A |
5627613 | Kaneko | May 1997 | A |
5628794 | Lindstrom | May 1997 | A |
5628795 | Langerman | May 1997 | A |
5628798 | Eggleston et al. | May 1997 | A |
5631243 | Kelman et al. | May 1997 | A |
5632773 | Graham et al. | May 1997 | A |
5643249 | Amano et al. | Jul 1997 | A |
5645582 | Silvestrini et al. | Jul 1997 | A |
5647865 | Swinger | Jul 1997 | A |
5653752 | Silvestrini et al. | Aug 1997 | A |
5662706 | Legerton et al. | Sep 1997 | A |
5662908 | Falkow et al. | Sep 1997 | A |
5672885 | Allen et al. | Sep 1997 | A |
5674724 | Miller, III et al. | Oct 1997 | A |
5674736 | Miller, III et al. | Oct 1997 | A |
5693092 | Silvestrini et al. | Dec 1997 | A |
5695983 | Miller et al. | Dec 1997 | A |
5697923 | Poler | Dec 1997 | A |
5697973 | Peyman et al. | Dec 1997 | A |
5702440 | Portney | Dec 1997 | A |
5713844 | Peyman | Feb 1998 | A |
5713957 | Steele et al. | Feb 1998 | A |
5719656 | Bowling | Feb 1998 | A |
5720894 | Neev et al. | Feb 1998 | A |
5722971 | Peyman | Mar 1998 | A |
5725575 | O'Donnell, Jr. | Mar 1998 | A |
5731196 | Miller, III et al. | Mar 1998 | A |
5731862 | Winkler | Mar 1998 | A |
5733334 | Lee et al. | Mar 1998 | A |
5733760 | Lu et al. | Mar 1998 | A |
5746558 | Nygren et al. | May 1998 | A |
5752960 | Nallakrishnan | May 1998 | A |
5752967 | Kritzinger et al. | May 1998 | A |
5757458 | Miller et al. | May 1998 | A |
5766171 | Silvestrini | Jun 1998 | A |
5769889 | Kelman | Jun 1998 | A |
5771088 | Perrott | Jun 1998 | A |
5771742 | Bokaie et al. | Jun 1998 | A |
5774202 | Abraham et al. | Jun 1998 | A |
5782911 | Herrick | Jul 1998 | A |
5785651 | Kuhn et al. | Jul 1998 | A |
5786883 | Miller et al. | Jul 1998 | A |
5800533 | Eggleston et al. | Sep 1998 | A |
5806530 | Herrick | Sep 1998 | A |
5814680 | Imafuku et al. | Sep 1998 | A |
5824086 | Silvestrini | Oct 1998 | A |
5833701 | Gordon | Nov 1998 | A |
5836313 | Perez et al. | Nov 1998 | A |
5840848 | Sturrock et al. | Nov 1998 | A |
5843105 | Mathis et al. | Dec 1998 | A |
5846186 | Upsher | Dec 1998 | A |
5846256 | Mathis et al. | Dec 1998 | A |
5855605 | Herrick | Jan 1999 | A |
5858980 | Weiner et al. | Jan 1999 | A |
5861486 | DeVore et al. | Jan 1999 | A |
5863537 | Dalie et al. | Jan 1999 | A |
5864128 | Plesko | Jan 1999 | A |
5864378 | Portney | Jan 1999 | A |
5865729 | Meehan et al. | Feb 1999 | A |
5870167 | Knopp et al. | Feb 1999 | A |
5874537 | Kelman et al. | Feb 1999 | A |
5876442 | Lipshitz et al. | Mar 1999 | A |
5888243 | Silverstrini | Mar 1999 | A |
5903099 | Johnson et al. | May 1999 | A |
5905561 | Lee et al. | May 1999 | A |
5919185 | Peyman | Jul 1999 | A |
5928283 | Gross et al. | Jul 1999 | A |
5929968 | Cotie et al. | Jul 1999 | A |
5935140 | Buratto | Aug 1999 | A |
5944752 | Silvestrini | Aug 1999 | A |
5960812 | Johnson | Oct 1999 | A |
5964748 | Peyman | Oct 1999 | A |
5964776 | Peyman | Oct 1999 | A |
5965330 | Evans et al. | Oct 1999 | A |
5968062 | Thomas et al. | Oct 1999 | A |
5980040 | Xu et al. | Nov 1999 | A |
5997559 | Ziemer | Dec 1999 | A |
6001386 | Ashton et al. | Dec 1999 | A |
6010510 | Brown et al. | Jan 2000 | A |
6010901 | Miller, III et al. | Jan 2000 | A |
6024447 | Portney | Feb 2000 | A |
6036957 | Weiner et al. | Mar 2000 | A |
D423669 | Huttner | Apr 2000 | S |
6050999 | Paraschac et al. | Apr 2000 | A |
6051023 | Kilmer et al. | Apr 2000 | A |
6063073 | Peyman | May 2000 | A |
6066171 | Lipshitz et al. | May 2000 | A |
6083236 | Feingold | Jul 2000 | A |
6086204 | Magnante | Jul 2000 | A |
6090141 | Lindstrom | Jul 2000 | A |
6096077 | Callahan et al. | Aug 2000 | A |
6102946 | Nigam | Aug 2000 | A |
6106552 | Lacombe et al. | Aug 2000 | A |
6110166 | Juhasz | Aug 2000 | A |
6125294 | Scholl et al. | Sep 2000 | A |
6126286 | Portney | Oct 2000 | A |
6138307 | McDonald | Oct 2000 | A |
6143010 | Silvestrini | Nov 2000 | A |
6161544 | DeVore et al. | Dec 2000 | A |
6164282 | Gwon et al. | Dec 2000 | A |
6165189 | Ziemer | Dec 2000 | A |
6171336 | Sawusch | Jan 2001 | B1 |
6175754 | Scholl et al. | Jan 2001 | B1 |
6176878 | Gwon et al. | Jan 2001 | B1 |
6178593 | Carlson | Jan 2001 | B1 |
6183498 | DeVore et al. | Feb 2001 | B1 |
D439338 | Huttner | Mar 2001 | S |
6197019 | Peyman | Mar 2001 | B1 |
6197057 | Peyman et al. | Mar 2001 | B1 |
6197934 | DeVore et al. | Mar 2001 | B1 |
6203538 | Peyman | Mar 2001 | B1 |
6204365 | Devore et al. | Mar 2001 | B1 |
6210005 | Portney | Apr 2001 | B1 |
6210401 | Lai | Apr 2001 | B1 |
6214044 | Silverstrini | Apr 2001 | B1 |
6217571 | Peyman | Apr 2001 | B1 |
6217596 | Farah | Apr 2001 | B1 |
6218360 | Cintron et al. | Apr 2001 | B1 |
6221067 | Peyman | Apr 2001 | B1 |
6221105 | Portney | Apr 2001 | B1 |
6228113 | Kauffman | May 2001 | B1 |
6228114 | Lee | May 2001 | B1 |
6231582 | Gandianco et al. | May 2001 | B1 |
6251118 | Proudfoot et al. | Jun 2001 | B1 |
6264648 | Peyman | Jul 2001 | B1 |
D447237 | Huttner et al. | Aug 2001 | S |
6277146 | Peyman et al. | Aug 2001 | B1 |
6280449 | Blake | Aug 2001 | B1 |
6280470 | Peyman | Aug 2001 | B1 |
6280471 | Peyman | Aug 2001 | B1 |
6283595 | Breger | Sep 2001 | B1 |
6302877 | Ruiz | Oct 2001 | B1 |
6308590 | Berto | Oct 2001 | B1 |
6312424 | Largent | Nov 2001 | B1 |
6376153 | Goodman et al. | Nov 2001 | B2 |
6335006 | Miller | Jan 2002 | B1 |
6357875 | Herrick | Mar 2002 | B1 |
6358280 | Herrick | Mar 2002 | B1 |
6361560 | Nigam | Mar 2002 | B1 |
6371973 | Tepper | Apr 2002 | B1 |
6387379 | Goldberg et al. | May 2002 | B1 |
6391055 | Ikada et al. | May 2002 | B1 |
6399734 | Hodd et al. | Jun 2002 | B1 |
6403947 | Hoyt et al. | Jun 2002 | B1 |
6406494 | Laguette et al. | Jun 2002 | B1 |
6413276 | Werblin | Jul 2002 | B1 |
6416179 | Lieberman et al. | Jul 2002 | B1 |
6423093 | Hicks et al. | Jul 2002 | B1 |
6425917 | Blake | Jul 2002 | B1 |
6436092 | Peyman | Aug 2002 | B1 |
6450642 | Jethmalani et al. | Sep 2002 | B1 |
6454800 | Dalton et al. | Sep 2002 | B2 |
6457826 | Lett | Oct 2002 | B1 |
6458141 | Peyman | Oct 2002 | B1 |
6470108 | Johnson | Oct 2002 | B1 |
6488707 | Callahan et al. | Dec 2002 | B1 |
6494910 | Ganem et al. | Dec 2002 | B1 |
6497700 | LaHaye | Dec 2002 | B1 |
6503276 | Lang et al. | Jan 2003 | B2 |
6515006 | Horn | Feb 2003 | B2 |
6520955 | Reynard | Feb 2003 | B2 |
6527389 | Portney | Mar 2003 | B2 |
6533905 | Johnson et al. | Mar 2003 | B2 |
6536899 | Fiala | Mar 2003 | B1 |
6551307 | Peyman | Apr 2003 | B2 |
6554424 | Miller et al. | Apr 2003 | B1 |
6555103 | Leukel et al. | Apr 2003 | B2 |
6569199 | Dotan et al. | May 2003 | B1 |
6575573 | Lai et al. | Jun 2003 | B2 |
6581993 | Nigam | Jun 2003 | B2 |
RE38193 | Bowling | Jul 2003 | E |
6588022 | Anders et al. | Jul 2003 | B1 |
6588902 | Isogai | Jul 2003 | B2 |
6589280 | Koziol | Jul 2003 | B1 |
6592621 | Domino | Jul 2003 | B1 |
6596026 | Gross et al. | Jul 2003 | B1 |
6599305 | Feingold | Jul 2003 | B1 |
6607527 | Ruiz et al. | Aug 2003 | B1 |
6607556 | Nigam | Aug 2003 | B1 |
6613088 | Babizhayev | Sep 2003 | B1 |
6614570 | Johnson et al. | Sep 2003 | B2 |
6620634 | Johnson et al. | Sep 2003 | B2 |
6623497 | Feingold | Sep 2003 | B1 |
6623522 | Nigam | Sep 2003 | B2 |
6624730 | Johnson et al. | Sep 2003 | B2 |
6626941 | Nigam | Sep 2003 | B2 |
6632244 | Nigam | Oct 2003 | B1 |
6638304 | Azar | Oct 2003 | B2 |
6663668 | Chaouk et al. | Dec 2003 | B1 |
6669795 | Johnson et al. | Dec 2003 | B2 |
6673112 | Nigam | Jan 2004 | B2 |
6692126 | Xie et al. | Feb 2004 | B1 |
6702807 | Peyman | Mar 2004 | B2 |
6729599 | Johnson | May 2004 | B2 |
6740116 | Morcher | May 2004 | B2 |
6742761 | Johnson et al. | Jun 2004 | B2 |
6746890 | Gupta et al. | Jun 2004 | B2 |
6749632 | Jethmalani et al. | Jun 2004 | B2 |
6755819 | Waelti | Jun 2004 | B1 |
6755858 | White | Jun 2004 | B1 |
D493889 | Yoo | Aug 2004 | S |
6786926 | Peyman | Sep 2004 | B2 |
6790298 | Johnson et al. | Sep 2004 | B2 |
6811256 | Becherer et al. | Nov 2004 | B1 |
6813097 | Jethmalani et al. | Nov 2004 | B2 |
6824266 | Jethmalani et al. | Nov 2004 | B2 |
6849090 | Nigam | Feb 2005 | B2 |
6851804 | Jethmalani et al. | Feb 2005 | B2 |
6855163 | Peyman | Feb 2005 | B2 |
6874886 | Miller et al. | Apr 2005 | B2 |
6899424 | Miller et al. | May 2005 | B2 |
6949093 | Peyman | Sep 2005 | B1 |
6951556 | Epstein | Oct 2005 | B2 |
6966648 | Miller et al. | Nov 2005 | B2 |
6976997 | Noolandi et al. | Dec 2005 | B2 |
6986763 | Holmen | Jan 2006 | B2 |
6989008 | Peyman | Jan 2006 | B2 |
7001374 | Peyman | Feb 2006 | B2 |
7008447 | Koziol | Mar 2006 | B2 |
7025455 | Roffman | Apr 2006 | B2 |
7097649 | Meyer | Aug 2006 | B2 |
7179292 | Worst et al. | Feb 2007 | B2 |
7207998 | Feingold | Apr 2007 | B2 |
7364674 | Hoover | Apr 2008 | B1 |
D569512 | Poll et al. | May 2008 | S |
D571915 | Poll et al. | Jun 2008 | S |
7404637 | Miller et al. | Jul 2008 | B2 |
7404638 | Miller et al. | Jul 2008 | B2 |
7462194 | Blake | Dec 2008 | B1 |
7491350 | Silvestrini | Feb 2009 | B2 |
D589615 | Doenges | Mar 2009 | S |
7628810 | Christie et al. | Dec 2009 | B2 |
7645291 | Ross et al. | Jan 2010 | B2 |
7645299 | Koziol | Jan 2010 | B2 |
7828844 | Marmo et al. | Nov 2010 | B2 |
7976577 | Silvestrini | Jul 2011 | B2 |
D645337 | Hsu et al. | Sep 2011 | S |
8079706 | Silvestrini et al. | Dec 2011 | B2 |
D656526 | Christie et al. | Mar 2012 | S |
8287592 | Silvestrini | Oct 2012 | B2 |
8343215 | Miller et al. | Jan 2013 | B2 |
D681086 | Christie et al. | Apr 2013 | S |
20010004702 | Peyman | Jun 2001 | A1 |
20010027314 | Peyman | Oct 2001 | A1 |
20010034516 | Peyman | Oct 2001 | A1 |
20010047203 | Dalton et al. | Nov 2001 | A1 |
20010050750 | Breger | Dec 2001 | A1 |
20020010510 | Silvestrini | Jan 2002 | A1 |
20020016629 | Sandstedt et al. | Feb 2002 | A1 |
20020028330 | Patel et al. | Mar 2002 | A1 |
20020042004 | Sandstedt et al. | Apr 2002 | A1 |
20020055753 | Silvestrini | May 2002 | A1 |
20020057148 | Johnson et al. | May 2002 | A1 |
20020075447 | Andino et al. | Jun 2002 | A1 |
20020082288 | Horn | Jun 2002 | A1 |
20020107337 | Rosenzweig et al. | Aug 2002 | A1 |
20020107566 | Nigam | Aug 2002 | A1 |
20020111677 | Nigam | Aug 2002 | A1 |
20020120329 | Lang et al. | Aug 2002 | A1 |
20020128710 | Eggleston | Sep 2002 | A1 |
20020133228 | Sarver | Sep 2002 | A1 |
20020138070 | Peyman | Sep 2002 | A1 |
20020167640 | Francis et al. | Nov 2002 | A1 |
20020167735 | Jethmalani et al. | Nov 2002 | A1 |
20020169491 | Foster et al. | Nov 2002 | A1 |
20020169505 | Jethmalani et al. | Nov 2002 | A1 |
20020173846 | Blake et al. | Nov 2002 | A1 |
20020188351 | Laguette | Dec 2002 | A1 |
20020196409 | Jani | Dec 2002 | A1 |
20030002994 | Johnson et al. | Jan 2003 | A1 |
20030007122 | Streibig | Jan 2003 | A1 |
20030014021 | Holmen | Jan 2003 | A1 |
20030014042 | Juhasz et al. | Jan 2003 | A1 |
20030014107 | Reynard | Jan 2003 | A1 |
20030033013 | Callahan et al. | Feb 2003 | A1 |
20030045930 | Nguyen | Mar 2003 | A1 |
20030048411 | Jethmalani et al. | Mar 2003 | A1 |
20030055497 | Hicks et al. | Mar 2003 | A1 |
20030071893 | Miller et al. | Apr 2003 | A1 |
20030078655 | Callahan et al. | Apr 2003 | A1 |
20030088313 | Nigam | May 2003 | A1 |
20030090013 | Jethmalani et al. | May 2003 | A1 |
20030090624 | Jethmalani et al. | May 2003 | A1 |
20030093083 | Peyman | May 2003 | A1 |
20030093150 | Jethmalani et al. | May 2003 | A1 |
20030105521 | Perez | Jun 2003 | A1 |
20030115718 | Bechthold | Jun 2003 | A1 |
20030127318 | Johnson et al. | Jul 2003 | A1 |
20030128336 | Jethmalani et al. | Jul 2003 | A1 |
20030151825 | Bielawski et al. | Aug 2003 | A1 |
20030151831 | Sandstedt et al. | Aug 2003 | A1 |
20030174375 | Jethmalani et al. | Sep 2003 | A1 |
20030176521 | Jethmalani et al. | Sep 2003 | A1 |
20030216763 | Patel | Nov 2003 | A1 |
20030220653 | Perez | Nov 2003 | A1 |
20040014253 | Gupta et al. | Jan 2004 | A1 |
20040015234 | Peyman | Jan 2004 | A1 |
20040019379 | Glick et al. | Jan 2004 | A1 |
20040047014 | Parker et al. | Mar 2004 | A1 |
20040068317 | Knight | Apr 2004 | A1 |
20040078075 | Koziol | Apr 2004 | A1 |
20040080239 | Gupta et al. | Apr 2004 | A1 |
20040086479 | Grinstaff et al. | May 2004 | A1 |
20040106929 | Masket | Jun 2004 | A1 |
20040243231 | Koziol | Dec 2004 | A1 |
20050027355 | Murakami | Feb 2005 | A1 |
20050031697 | Vehige et al. | Feb 2005 | A1 |
20050046794 | Silvestrini et al. | Mar 2005 | A1 |
20050049621 | Feingold et al. | Mar 2005 | A1 |
20050080485 | Nigam | Apr 2005 | A1 |
20050090895 | Peyman | Apr 2005 | A1 |
20050099597 | Sandstedt et al. | May 2005 | A1 |
20050119738 | Nigam | Jun 2005 | A1 |
20050124983 | Fret et al. | Jun 2005 | A1 |
20050143717 | Peyman | Jun 2005 | A1 |
20050143812 | Paul et al. | Jun 2005 | A1 |
20050182488 | Peyman | Aug 2005 | A1 |
20050187621 | Brady | Aug 2005 | A1 |
20050222679 | Peyman | Oct 2005 | A1 |
20050228376 | Boomer et al. | Oct 2005 | A1 |
20050246015 | Miller | Nov 2005 | A1 |
20050246016 | Miller et al. | Nov 2005 | A1 |
20050246019 | Blake et al. | Nov 2005 | A1 |
20060079959 | Christie et al. | Apr 2006 | A1 |
20060079960 | Christie et al. | Apr 2006 | A1 |
20060095127 | Feingold et al. | May 2006 | A1 |
20060098162 | Bandhauer et al. | May 2006 | A1 |
20060113054 | Silvestrini | Jun 2006 | A1 |
20060184243 | Yilmaz | Aug 2006 | A1 |
20060235428 | Silvestrini | Oct 2006 | A1 |
20060241751 | Marmo et al. | Oct 2006 | A1 |
20060265058 | Silvestrini | Nov 2006 | A1 |
20060268226 | Christie et al. | Nov 2006 | A1 |
20060268227 | Christie et al. | Nov 2006 | A1 |
20060268228 | Christie et al. | Nov 2006 | A1 |
20060268229 | Silvestrini et al. | Nov 2006 | A1 |
20060270946 | Silvestrini et al. | Nov 2006 | A1 |
20060271026 | Silvestrini et al. | Nov 2006 | A1 |
20060271027 | Silvestrini et al. | Nov 2006 | A1 |
20060271176 | Christie et al. | Nov 2006 | A1 |
20060271177 | Christie et al. | Nov 2006 | A1 |
20060271178 | Christie et al. | Nov 2006 | A1 |
20060271179 | Christie et al. | Nov 2006 | A1 |
20060271180 | Christie et al. | Nov 2006 | A1 |
20060271181 | Christie et al. | Nov 2006 | A1 |
20060271182 | Christie et al. | Nov 2006 | A1 |
20060271183 | Christie et al. | Nov 2006 | A1 |
20060271184 | Silvestrini | Nov 2006 | A1 |
20060271185 | Silvestrini | Nov 2006 | A1 |
20060274264 | Christie et al. | Dec 2006 | A1 |
20060274265 | Christie et al. | Dec 2006 | A1 |
20070016234 | Daxer | Jan 2007 | A1 |
20070129797 | Lang et al. | Jun 2007 | A1 |
20070219542 | Yahagi | Sep 2007 | A1 |
20080033546 | Liang | Feb 2008 | A1 |
20080077238 | Deacon et al. | Mar 2008 | A1 |
20080125862 | Blake | May 2008 | A1 |
20080151183 | Altmann | Jun 2008 | A1 |
20080212030 | Bentley et al. | Sep 2008 | A1 |
20080275462 | Feingold | Nov 2008 | A1 |
20090012505 | Chernyak | Jan 2009 | A1 |
20090059168 | Miller et al. | Mar 2009 | A1 |
20090069817 | Peyman | Mar 2009 | A1 |
20090204207 | Blum et al. | Aug 2009 | A1 |
20090222086 | Lui et al. | Sep 2009 | A1 |
20090306773 | Silversrini et al. | Dec 2009 | A1 |
20100312336 | Hong et al. | Dec 2010 | A1 |
20110040376 | Christie et al. | Feb 2011 | A1 |
20110172675 | Danta et al. | Jul 2011 | A1 |
20120143325 | Christie et al. | Jun 2012 | A1 |
20120203239 | Vukich et al. | Aug 2012 | A1 |
20120245683 | Christie et al. | Sep 2012 | A1 |
20120310338 | Christie et al. | Dec 2012 | A1 |
20130238091 | Danta et al. | Sep 2013 | A1 |
20130268071 | Vilupuru et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
241 330 | Dec 1992 | AR |
241 830 | Dec 1992 | AR |
244 890 | Nov 1993 | AR |
739297 | Jan 2002 | AU |
0772492 | Aug 2004 | AU |
778310 | Mar 2005 | AU |
2003252004 | Mar 2010 | AU |
2006236715 | Jun 2012 | AU |
2286718 | Nov 2008 | CA |
1253484 | May 2000 | CN |
101198294 | Jun 2008 | CN |
101198364 | Jun 2008 | CN |
102448404 | May 2012 | CN |
102470033 | May 2012 | CN |
3433581 | Mar 1986 | DE |
41 34 320 | Apr 1992 | DE |
0165652 | Dec 1985 | EP |
0225098 | Jun 1987 | EP |
0286433 | Oct 1988 | EP |
0443094 | Aug 1991 | EP |
0457553 | Nov 1991 | EP |
0941717 | Sep 1999 | EP |
1014872 | Jul 2000 | EP |
1173790 | Jan 2002 | EP |
1267998 | Jan 2003 | EP |
1381326 | Jan 2004 | EP |
1871298 | Apr 2006 | EP |
1159033 | Jan 2007 | EP |
1827330 | Sep 2007 | EP |
1845896 | Oct 2007 | EP |
1890736 | Feb 2008 | EP |
1158936 | Jul 2008 | EP |
1997530 | Dec 2008 | EP |
1534188 | Sep 2010 | EP |
2258311 | Dec 2010 | EP |
2301477 | Mar 2011 | EP |
1635739 | Sep 2011 | EP |
2464310 | Jun 2012 | EP |
2464311 | Jun 2012 | EP |
2506803 | Oct 2012 | EP |
369 993 | Jan 1907 | FR |
1115140 | Dec 1955 | FR |
1400566 | Apr 1965 | FR |
2599156 | May 1986 | FR |
2649605 | Jan 1991 | FR |
1 026 839 | Apr 1966 | GB |
1276003 | Jun 1972 | GB |
1028531 | Feb 2011 | HK |
1151451 | Feb 2012 | HK |
11553484 | May 2012 | HK |
1166457 | Nov 2012 | HK |
62167343 | Jul 1987 | JP |
63-17096 | Apr 1988 | JP |
64-002644 | Jan 1989 | JP |
03-001857 | Jan 1991 | JP |
04-158859 | Jun 1992 | JP |
04-223425 | Aug 1992 | JP |
6-502782 | Mar 1994 | JP |
6-509731 | Nov 1994 | JP |
07-050242 | Feb 1995 | JP |
07-178125 | Jul 1995 | JP |
07-265340 | Oct 1995 | JP |
08-103457 | Apr 1996 | JP |
2002-14772 | Jan 2002 | JP |
2003-527228 | Sep 2003 | JP |
2004-510199 | Apr 2004 | JP |
2004-538034 | Dec 2004 | JP |
4114036 | Apr 2008 | JP |
2008-517671 | May 2008 | JP |
2008-536574 | Sep 2008 | JP |
2008-536576 | Sep 2008 | JP |
4182390 | Sep 2008 | JP |
2010-227615 | Oct 2010 | JP |
2010-126600 | Feb 2011 | JP |
10-1304014 | Aug 2013 | KR |
1380743 | Mar 1998 | RU |
2138837 | Sep 1999 | RU |
WO 8705797 | Oct 1987 | WO |
WO 8707165 | Dec 1987 | WO |
WO 9116865 | Nov 1991 | WO |
WO 9205694 | Apr 1992 | WO |
WO 9303776 | Mar 1993 | WO |
WO 9308878 | May 1993 | WO |
WO 9312735 | Jul 1993 | WO |
WO 9320763 | Oct 1993 | WO |
WO 9401058 | Jan 1994 | WO |
WO 9405232 | Mar 1994 | WO |
WO 9423327 | Oct 1994 | WO |
WO 9502356 | Jan 1995 | WO |
WO 9503747 | Feb 1995 | WO |
WO 9508135 | Mar 1995 | WO |
WO 9635397 | Nov 1996 | WO |
WO 9728759 | Aug 1997 | WO |
WO 9748004 | Dec 1997 | WO |
WO 9748005 | Dec 1997 | WO |
WO 9827896 | Jul 1998 | WO |
WO 9848715 | Nov 1998 | WO |
WO 9907309 | Feb 1999 | WO |
WO 0025704 | May 2000 | WO |
WO 0038594 | Jul 2000 | WO |
WO 0051682 | Sep 2000 | WO |
WO 0052516 | Sep 2000 | WO |
WO 0052516 | Jan 2001 | WO |
WO 0110641 | Feb 2001 | WO |
WO 0115779 | Mar 2001 | WO |
WO 0117460 | Mar 2001 | WO |
WO 0119364 | Mar 2001 | WO |
WO 0182815 | Nov 2001 | WO |
WO 0187189 | Nov 2001 | WO |
WO 0213881 | Feb 2002 | WO |
WO 0227388 | Apr 2002 | WO |
WO 02076320 | Oct 2002 | WO |
WO 02102241 | Dec 2002 | WO |
WO 03022168 | Mar 2003 | WO |
WO 03030763 | Apr 2003 | WO |
WO 03061518 | Jul 2003 | WO |
WO 2004014969 | Feb 2004 | WO |
WO 2004034917 | Apr 2004 | WO |
WO 2004050132 | Jun 2004 | WO |
WO 2004105588 | Dec 2004 | WO |
WO 2005082265 | Sep 2005 | WO |
WO 2006020638 | Feb 2006 | WO |
WO 2006047534 | May 2006 | WO |
WO 2006047698 | May 2006 | WO |
WO 2006060380 | Jun 2006 | WO |
WO 2006113377 | Oct 2006 | WO |
WO 2006113411 | Oct 2006 | WO |
WO 2006113474 | Oct 2006 | WO |
WO 2006113563 | Oct 2006 | WO |
WO 2006113564 | Oct 2006 | WO |
WO 2007057734 | May 2007 | WO |
WO 2007142981 | Dec 2007 | WO |
WO 2008036671 | Mar 2008 | WO |
WO 2008121649 | Oct 2008 | WO |
WO 2009149060 | Dec 2009 | WO |
WO 2011020074 | Feb 2011 | WO |
WO 2011020078 | Feb 2011 | WO |
WO 2011047076 | Apr 2011 | WO |
WO 2011069059 | Jun 2011 | WO |
WO 2011088107 | Jul 2011 | WO |
WO 2013082545 | Jun 2013 | WO |
Entry |
---|
Accommodation and acuity under night-driving illumination levels. Arumi et al. Ophthal. Physiol. Opt. vol. 17, No. 4, pp. 291-299, Jul. 1997. |
Accommodation and Presbyopia. Croft et al., International Ophthalmology Clinics: Mar. 2001, vol. 41, Issue 2, pp. 33-46. |
Accommodation dynamics as a function of age. Heron et al. Ophthal. Physiol. Opt. Nov. 2002. 22(5):389-396. |
Accommodation Responses and Ageing. Heron et al. IOVS, Nov. 1999, vol. 40, No. 12, pp. 2872-2883. |
Accommodative responses to anisoaccommodative targets. Koh et al. Ophthal. Physiol. Opt. vol. 18, No. 3, pp. 254-262, May 1998. |
Accommodation responses to flickering stimuli. Chauhan et al. Ophthal. Physiol. Opt. vol. 16. No. 5, pp. 391-408, Sep. 1996. |
Accommodation to perceived depth in stereo tests. Koh et al. Ophthal. Physiol. Opt. vol. 18, No. 3, pp. 279-284, May 1998. |
Age Changes in the Interactions between the Accommodation and Vergence Systems. Heron et al. Optometry and Vision Science. vol. 78, No. 10, Oct. 2001. |
Anterior Ciliary Sclerotomy for Treatment of Presbyopia: A Prospective Controlled Study. Hamilton et al. Ophthalmology, vol. 109, No. 11: Nov. 2002: pp. 1970-1977. |
Binder et al., “Hydrogel keratophakia in non-human primates”, Current Eye Research, vol. 1, No. 9, Jan. 1981, pp. 535-542. |
Brooks, J. et al., Identification of a Vimentin-Reactive Peptide Associated with Ocular Lens Membranes as Cytokeratin, Ophthalmic Res., Jan.-Feb. 2003, pp. 8-11, vol. 35. |
Cao et al., “Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage”, Polymers for Tissue Engineering, pp. 315-327, VSP Jan. 1998. |
Can Accommodation be Surgically Restored in Human Presbyopia? Glasser, Adrian. Optometry and Vision Science, vol. 76, No. 9, Sep. 1999. |
Changes in the static accommodation response with age. Kalsi et al. Ophthal. Physiol. Opt. vol. 21, No. 1, pp. 77-84, Jan. 2001. |
Choice of Spatial Frequency for Contrast Sensitivity Evaluation After Corneal Refractive Surgery. Montes-Mico et al. Journal of Refractive Surgery, vol. 17: Nov./Dec. 2001: pp. 646-651. |
Chow, C., et al., Broadband optical ultrasound sensor with a unique open-cavity structure, J. Biomed. Opt., Jan.-Feb. 2011, pp. 017001, vol. 16. |
Choyce, P. “Implants with Coloured and Opaque Portions: Implants with Built-In Stenopeic Aperture,” pp. 21-26 “Uniocular Aphakia Corrected by Anterior Chamber Implants with Built-In Stenopeic Aperture,” pp. 132-136, 1964. |
Clinical Characteristics of Lamellar Channel Deposits After Implementation of Intacs. Ruckhofer et al. J Cataract Refract Surg, vol. 26, Oct. 2000: pp. 1473-1479. |
Contemporary Polymer Applications for Corneal Surgery. McCarey, Bernard E. pp. 504-505, Department of Ophthalmology, Emory University, Atlanta Georgia 30322. |
Cotliar et al., “Excimer Laser Radial Keratotomy”, Ophthalmology, 1985. |
Corneal Topography: The State of the Art, Alignment of Videokeratographs. Mandell et al. Chpt. 2, pp. 17-23, Jan. 1995. |
“Corneal Surgery” by L. Girard, The C.V. Mosby Publishing Company, London 1981 pp. 107-141. |
Dynamics of the accommodation response to abrupt changes in target vergence as a function of age. Heron et al. Vision Research 41 (4) 507-519, Feb. 2001. |
Dynamic retinoscopy and accomodation. Whitefoot et al. Ophthal. Physiol. Opt. vol. 12, Jan. 1992, pp. 8-17. |
Eduard Jaeger's Test-Types (Schrift-Scalen) and Historical Development of Vision Tests. Runge, Paul E. Tr. Am. Ophth. Soc. vol. 98, 2000: 375. |
Eight Years Experience with Permalens Intracorneal Lenses in Nonhuman Primates. Werblin et al. Refractive & Corneal Surgery, vol. 8, Jan./Feb. 1992, pp. 12-21. |
“Epikeratophakia: Techniques, Compositions, and Clinical Results” by Werblin, Ophthalmology, 1983, pp. 45-58. |
Errors in determining the direction of the visual axis in the presence of defocus. Atchison et al. Ophthal. Physiol. Opt., vol. 18, No. 5, pp. 463-467, Sep. 1998. |
Evaluate surgical routine to determine DLK cause, surgeon advises. Piechocki, Michael. Ocular Surgery News: Refractive Surgery, Jan. 1, 2003: p. 14. |
Explanation for the observation of isogyres in crystalline lenses viewed between crossed polarizers. Ophthal. Physiol. Opt., vol. 13, Apr. 1993, pp. 209-211. |
FDA Summary of Safety and Effectiveness Data for Tecnis Multifocal Posterior Chamber Intraocular Lens, Models ZM900 and ZMA00, 2009. |
FDA Summary of Safety and Effectiveness Data for the Advanced Vision Science, Inc. XACT Foldable Hydrophobic Acrylic Ultraviolet Light-Absorbing Posterior Chamber Intraocular Lens (Model X-60 and Model X-70), 2009. |
FDA Summary of Safety and Effectiveness Data for EC-3 IOL, (Models EC-3 IOL and EC-3 Precision Aspheric Lens), 2010. |
FDA Summary of Safety and Effectiveness Data for Aaren Scientific's EC-3 IOL, 2010. |
FDA Summary of Safety and Effectiveness Data for XACT Foldable Hydrophobic Acrylic UV Absorbing Posterior Chamber Intraocular Lens discussing clinical investigation beginning on May 8, 2002. |
Flap Measurements With the Hansatome Microkeratome. Spadea et al. Journal of Refractive Surgery, vol. 18, Mar./Apr. 2002: pp. 149-154. |
Focused and divided attention in stereoscopic depth. Wickens et al. SPIE, vol. 1256 Stereoscopic Displays and Applications (1990); pp. 28-34. |
Gamez, G., et al., Development of a pulsed radio frequency glow discharge for three-dimensional elemental surface imaging. 1. Application to biopolymer analysis, Anal. Chem., Feb. 2007, pp. 1317-1326, vol. 79. |
Glasier, M., et al., A solid-phase assay for the quantitation of total protein eluted from balafilcon, lotrafilcon, and etafilcon contact lenses, Current Eye Research, Jan. 2008, pp. 631-640, vol. 33. |
Griffith et al.; “Functional Human Corneal Equivalents Constructed from Cell Lines”, Science, vol. 286, Dec. 10, 1999 pp. 2169-2172. |
Groppi, J. J. “New Aspects in the Fitting of the Multi-Range Bifocal Contact Lens” Contacto, vol. 15:22-29, Jun. 1971. |
Hara, T., et al., Accommodative intraocular lens with spring action. Part 1. Design and placement in an excised animal eye, Ophthalmic Surg., Feb. 1990, vol. 21. |
Hara, T., et al., Ten-year results of anterior chamber fixation of the posterior chamber intraocular lens, Arch. Ophthalmol., Aug. 2004, pp. 1112-1116. |
Hayasaka, S., et al., Scanning electron microscopic study of polyvinylidene fluoride degradation by ocular tissue extracts, Jpn. J. Ophthalmol., Mar. 1984, pp. 131-135, vol. 28. |
Hayashi, K., et al., Intraocular lens factors that may affect anterior capsule contraction, Ophthalmology, Feb. 2005, pp. 286-292, vol. 112. |
Hayashi, K., et al., Comparison of decentration and tilt between one piece and three piece polymethyl methacrylate intraocular lenses, Br. J. Ophthalmol., Apr. 1998, pp. 419-422, vol. 82. |
Hidaka, T., et al, Adaptive optics instrumentation in submillimeter/terahertz spectroscopy with a flexible polyvinylidene fluoride cladding hollow waveguide, Rev. Sci. Instrum., 2007, pp. 25-26, vol. 78. |
Hoffer et al., “UCLA Clinical Trial of Radial Keratotomy” Opthalmology, Aug. 1981; 88:729-736. |
Holes in Clear Lenses Demonstrate a Pinhole Effect. Zacharia et al. Arch Ophthalmol, vol. 106, Apr. 1988, pp. 511-513. |
Human Visual System-Image Formation, Encyclopedia of Imaging Science and Technology, Roorda, A., 2002, pp. 539-557. |
Hybrid diffractive-refractive achromatic spectacle lenses. Charman, W. N. Ophthal. Physiol. Opt., vol. 14, Oct. 1994: pp. 389-392. |
Iijima et al. “Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver”, Polymers for Tissue Engineering, pp. 273-286, VSP Jan. 1998. |
Imaging in the 21st century. Charman, W. N. Ophthal. Physiol. Opt., vol. 18, No. 2, pp. 210-223, Mar. 1998. |
International Search Report and Written Opinion of the ISA, dated Aug. 28, 2006, PCT/US2006/014027, 15 pgs. |
International Search Report and Written Opinion of the ISA in related application, PCT/US2005/038428, mailed Apr. 6, 2006. |
International Search Report and Written Opinion in PCT Application No. PCT/US/2005/043108 dated Aug. 30, 2006 in 16 pages. |
International Search Report and Written Opinion in PCT Application No. PCT/US/2009/045929 dated Jun. 8, 2009 in 15 pages. |
International Search Report and Written Opinion in PCT Application No. PCT/US10/58879 dated Apr. 19, 2011 in 19 pages. |
International Search Report and Written Opinion in PCT/US2012/067466 mailed Feb. 8, 2013 in 23 pages. |
Intra-Ocular Lenses and Implants. Choyce, Peter. Chpts.4 & 17, 1964. |
Intraocular pressure after excimer laser myopic refractive surgery. Montes-Mico et al. Ophthal. Physiol. Opt., vol. 21, No. 3, pp. 228-235, 2001. |
Intrastromal Crystalline Deposits Following Hydrogel Keratophakia in Monkeys. Parks et al. Cornea, 12(1): 29-34, Jan. 1993. |
Izak, A., et al., Loop memory of haptic materials in posterior chamber intraocular lenses, J. Cataract Refract. Surg., Jul. 2002, pp. 1129-1135, vol. 28. |
“Katena Eye Instruments Catalog—Blaydes” dated Feb. 22, 2010, obtained from the Internet at: www.katena.com/html/product—detail.cfm in 1 page and printed on Feb. 22, 2010. |
Kenyon. “Recurrent Corneal Erosion: Pathogenesis and Therapy,” Summer 1978, pp. 169-195. |
“Keratomileusis for Myopia and Aphakia”, by Barraquer, Ophthalmology, Rochester 88(8):701-708, Aug. 1981. |
“Keratomileusis and Keratophakia in the Surgical Correction of Aphakia” by Barraquer, Cataract Surgery and Special Techniques, prior to 1996 pp. 270-289. |
Khodadoust et al., “Adhesion of Regenerating Corneal Epithelium,” Am. J. of Opthalmology, Mar. 1968, pp. 339-348. |
Kimura, W., et al., Comparison of shape recovery ratios in various IOL haptics, Nippon Ganka Gakkai Zasshi, Jun. 1991, pp. 548-555, vol. 95. |
Kimura, W., et al., Comparison of shape recovery ratios in various intraocular lens haptics, J. Cataract. Refract. Surg., Nov. 1992, pp. 547-553, vol. 18. |
Kimura, W., et al., Comparison of shape recovery ratios of single-piece poly(methyl methacrylate) intraocular lens haptics., J. Cataract. Refract. Surg., Sep. 1993, pp. 635-639, vol. 19. |
Ko, A., et al., Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis, Arch. Ophthalmol., Apr. 2011, pp. 415-420, vol. 129. |
Kocak, N., et al., Intraocular lens haptic fracturing with the neodymium:YAG laser In vitro study, J. Cataract Refract. Surg., Apr. 2006, pp. 662-665, vol. 32. |
“Lamellar Corneal Stromectomy for the Operative Treatment of Myopia” by Tadeusz Krwawicz, Notes, Cases, Instruments—1964, pp. 828-833. |
Lipid Deposits Posterior to Impermeable Intracorneal Lenses in Rhesus Monkeys: Clinical, Histochemical, and Ultrastructural Studies. Rodrigues et al. Refractive & Corneal Surgery, vol. 6, Jan./Feb. 1990: DO. 32-37. |
Lu Xuequan. Zhai Madlin, Li Jiuqiang, Ha Hongfei: “Radiation preparation and thermo-response swelling of interpenetrating polymer network hydrogel composed of PNIPAAm and PMMA” Radiation Physics and Chemistry, vol. 57, 2000, pp. 477-480, XP002473596. |
Mastel Precision: Fiber Optic Ring Illuminator (Product Nos. 3776 & 4050) US Patent No. 5312393, User Manual. Rev: A02: Jan. 11, 1995, pp. 1-25. |
Mastel Precision: The Ring Light. http://www.mastel.com/ring—light.html. Jul. 28, 2003. |
Measurement of the wave-front aberration of the eye by a fast psychophysical procedure. He et al. J. Opt. Soc. Am. A, vol. 15, No. 9: Sep. 1998, pp. 2449-2455. |
Microstructural Changes in Polyester Biotextiles During Implantation in Humans. King et al. NC State University: JTATM, vol. 1, Issue 3, Spring 2001, pp. 1-8. |
Miller et al. “Quantification of the Pinhole effect” Perspectives in Refraction, vol. 21:347-350. Jan. 1977. |
Moran, C., et al. Polyvinylidene flouride polymer applied in an intraocular pressure sensor, Jpn. J. Appl. Phys., Jun. 2005, pp. L885-L887, vol. 44, Issue 27. |
Near vision, lags of accommodation and myopia. Charman, W. N. Ophthal. Physiol. Opt., vol. 19, No. 2, pp. 126-133, Mar. 1999. |
New Visual Acuity Charts for Clinical Research. Ferris et al. American Journal of Ophthalmology, 94: 91-96, Jul. 1982. |
Night myopia and driving. Charman, W. N. Ophthal. Physiol. Opt., vol. 16, No. 6, p. 474-485, Nov. 1996. |
Notch in contrast sensitivity function of optical origin: diffraction effects of acrylic filters. Irving et al., Ophthal. Physiol. Opt., vol. 13, Apr. 1993: pp. 179-182. |
On modeling the causes of presbyopia. Glasser, A. Vision Research 41(24) 3083-3087, Nov. 2001. |
On the linearity of accommodation dynamics. Charman, W. N. Vision Research 40 (15) 2057-2066, 2000. |
Optical Aspects of Tolerances to Uncorrected Ocular Astigmatism. Charman et al. Optometry and Vision Science, vol. 70, No. 2: pp. 111-117, Feb. 1993. |
Optical Modeling of Contact Lens Performance Final Report Covering Period Jul. 15, 1994-Mar. 31, 1995. Grivenkamp et al. for Pilkington Barnes Hind, Issued Apr. 5, 1995. |
Optometric Clinical Practice Guideline Care of the Patient With Presbyopia: Reference Guide for Clinicians. Mancil et al. Mar. 20, 1998. |
Ozanics et al., “Prenatal Development of the Eye and its Adnexa,” Biomedical Foundation of Ophthalmology, 1985, vol. 1, Chap 2, pp. 7-15. |
Patel, C.K., et al. “Imaging the macula through a black occlusive intraocular lens”. Arch. Ophthalmol. Oct. 2010; 128(10):1374-1376. |
PCT/US00/05136 International Search Report, dated Aug. 18, 2000, 9 pp. |
PCT/US04/16914 International Search Report and Written Opinion, dated Apr. 13, 2005, 9 pp. |
PCT/US2010/045548 International Search Report and Written Opinion, dated Dec. 20, 2010 in 19 pages. |
PCT/US2010/052538 International Search Report and Written Opinion, dated Dec. 6, 2010, 12 pp. |
PCT/US2010/045541 International Search Report and Written Opinion dated Oct. 1, 2010 in 9 pages. |
PermaVision intracorneal lens shows promise for hyperopia. Kronemyer, Bob. Ocular Surgery News: Jan. 1, 2003; p. 8. |
Perspectives in Refraction: Quantification of the Pinhole Effect. Miller et al. Survey of Ophthalmology, vol. 21, No. 4, Jan./Feb. 1977, pp. 347-350. |
Peyman et al., “Modification of Rabbit Corneal Curvature with use of Carbon Dioxide Laser Burns,” Ophth, Surg., vol. 11, No. 5, pp. 325-329, May 1980. |
Puliafito, C., et al., “Excimer Laser Ablator of the Cornea & Lens,” Ophthalmology, vol. 92 No. 6, pp. 741-748, Jun. 1985. |
Sally Pobojewski, “New U-developed laser performs high-precision corneal surgery”, News and Information Services, The University Record, Jul. 16, 1997. |
Poly(methyl methacrylate) model study of optical surface quality after excimer laser photo refractive keratectomy. Hauge et al. J Cataract Refract Surg., vol. 27, Dec. 2001, pp. 2026-2035. |
Prince, S., et al., Sorption of alkylbenzyldimethylammonium chloride homologs to various filter media used in processing ophthalmics, APhA Annual Meeting, 1996, pp. 103, vol. 143. |
Procyon: Marketing Information for Distributors: Pupil Measurement and Refractive Surgery (Samples from Academic Papers 1994 and 2002). pp. 1-17. |
“Refractive Keratoplasty: Acute Morphologic Features,” by Baumgarter et al, The CLAO Journal. Apr. 1985, vol. II, No. 2, pp. 163-169. |
Refractive keratoplasty with intrastromal hydrogel lenticular implants. McCarey et al. Invest., Ophthalmol. Vis. ScL, Jul. 1981, pp. 107-115. |
Retinal Image Quality in the Human Eye as a Function of the Accommodation. Lopez-Gil et al. Vision Research, vol. 38, No. 19,Jul. 3, 1998, pp. 1-11. |
Rosenbloom “The Controlled-Pupil Contact Lens in Low Vision Problems” Journal of the American Optometric Association, pp. 836, 838, 840 1969. |
Sato, “A New Surgical Approach to Myopia”, Am. J. Ophthalmol. 36:823, 1953. |
Shingleton, B., Reply: pupil stretch technique, J. Cataract Refract. Surg., 2007, pp. 362, vol. 33. |
Simple parametric model of the human ocular modulation transfer function, A. Deeley et al. Ophthal. Physiol. Opt., vol. 11, Jan. 1991, pp. 91-93. |
Karin R. Slettin, MD et al., “An In Vivo Model of Femtosecond Laser Intrastromal Refractive Surgery”, Experimental Science, Ophthalmic Surgery and Lasers, Nov./Dec. 1999, vol. 30, No. 9, pp. 742-749. |
Subjective Depth-of-Focus of the Eye. Atchison et al. Optometry and Vision Science, vol. 74, No. 7, Jul. 1997, pp. 511-520. |
Subjective Sensitivity to Small Changes in the Contrast of a Suprathreshold Grating, The. Walsh et al. Vision Res., vol. 30, No. 1, pp. 163-193, 1990. |
Surface Modification Properties of Parylene for Medical Applications, The. Wolgemuth, Lonny.Business Briefing: Medical Device Manufacturing & Technology 2002, pp. 1-4. |
Surface tension control of collagen biomaterials by the selective hydrolysis of internal carboxyamides of the protein matrix. Revista Brasileira de Engenharia Biomedica, v. 15, n. 1-2, p. 55-61, Jan./ago 1999. |
Surgeon: Severe corneal lesions after LASIK are not stage 4 DLK. Piechocki, Michael. Ocular SurgeryNews; Jan. 1, 2003, pp. 16-17. |
Subrayan, V., et al., Improving quality of vision with an anterior surface modified prolate intraocular lens: A prospective clinical trial, Int. J. Ophthalmol., Aug. 2007, pp. 918-920, vol. 7, No. 4. |
Swinger et al., “Keratophakia and Keratomileusis-Clinical Results”, American Academy of Ophthalmology, Aug. 1981, vol. 88, No. 8, pp. 709-715. |
Taboda, J., et al., “Response of the Corneal Epithelium to K.F. Excimer Laser Pulses,” Health Physics, 1981, vol. 40, pp. 677-683. |
Takahashi, E. “Use and Interpretation of the Pinhole Test” The Optometric Weekly, pp. 83-86 1965. |
Tasaki, I., et al., Demonstration of heat production associated with spreading depression in the amphibian retina, Biochem. Biophys. Res. Commun., 1991, pp. 293-297, vol. 174. |
Theoretical and practical performance of a concentric bifocal intraocular implant lens. Charman, W.N. Vision Research 38 (1998) 2841-2853. |
Trokel, S., et al., “Excimer Laser Surgery of the Cornea,” Am. J. Opthalmology, 1983 vol. 96, pp. 710-715. |
Use of a digital infrared pupillometer to assess patient suitability for refractive surgery. Rosen et al. J Cataract Refract Surg., vol. 28: Aug. 2002. pp. 1433-1438. |
Vision and driving—a literature review and commentary. Charman, W.N. Ophthal. Physiol. Opt., vol. 17, No. 5, pp. 371-391, 1997. |
Wesley, N. K. “Research on the Multi-Range Lens,” pp. 18-24, 1970. |
Yamauchi et al., “Cultivation of fibroblast cells on keratin coated substrata”, Polymers for Tissue Engineering, pp. 329-340, VS Jan. 1998. |
Yusuf, et al., “Inability to perform posterior segment monitoring by scanning laser ophthalmoscopy or optical coherence tomography with some occlusive intraocular lenses in clinical use”, J. Cataract Refract. Surg., Mar. 2012, 38: 513-513. |
Yusuf, et al., “Occlusive IOLs for Intractable Diplopia Demonstrate a Novel Near-Infrared Window of Transmission for SLO/OCT Imaging and Clinical Assessment”. Investigative Ophthalmology & Visual Science, May 2011, 52(6): 3737-3743. |
Zavala et al., “Refractive Keratoplasty: Lathing and Cyropreservation,” CLAO Journal, Apr. 1985, 11:155-162. |
International Search Report and Written Opinion in PCT/US2013/026234 mailed May 15, 2013 in 13 pages. |
Number | Date | Country | |
---|---|---|---|
20130131795 A1 | May 2013 | US |
Number | Date | Country | |
---|---|---|---|
60122001 | Mar 1999 | US | |
60124345 | Mar 1999 | US | |
60138110 | Jun 1999 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11284791 | Nov 2005 | US |
Child | 12182056 | US | |
Parent | 10729200 | Dec 2003 | US |
Child | 11284791 | US | |
Parent | 10384957 | Mar 2003 | US |
Child | 10729200 | US | |
Parent | 09516258 | Feb 2000 | US |
Child | 10384957 | US | |
Parent | 09516258 | Feb 2000 | US |
Child | 09516258 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12182056 | Jul 2008 | US |
Child | 13692864 | US |